Navigation Links
ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
Date:11/12/2008

lso reported visiting an average of 4.4 different physicians before receiving an accurate diagnosis of HAE. In addition, survey participants had an average of two immediate and two extended family members that had been diagnosed with HAE, but only 48 percent of their immediate family members and 26 percent of their extended family members had been tested for HAE.

"Accurate, timely diagnosis of HAE patients continues to be a challenge, and despite the fact that HAE is a hereditary disorder, testing family members is not common practice; a consensus statement may lead to improved and earlier diagnosis of patients with HAE," said Timothy Craig, DO, professor of medicine, Penn State University, who co-presented the survey data. "These findings indicate that testing family members for HAE should be a primary concern for those caring for patients with the disorder, and patients should be alerted to the need for screening of their family members."

About Cinryze C1 Inhibitor (human)

Cinryze is a highly purified, pasteurized and nanofiltered plasma-derived C1 inhibitor product that has been approved by FDA for routine prophylaxis against angioedema attacks in adolescent and adult patients with HAE. C1 inhibitor therapy has been used acutely for more than 30 years in Europe to treat patients with C1 inhibitor deficiency. Cinryze has not been approved for acute treatment in the United States or any other jurisdiction.

Cinryze has been well tolerated. The most common adverse reactions observed have been upper respiratory infection, sinusitis, rash and headache. No drug-related serious adverse events (SAEs) have been observed in clinical trials. Severe hypersensitivity reactions may occur. Thrombotic events have occurred in patients receiving high dose off-label C1 inhibitor therapy well above the approved treatment dosage regimen. With any blood or plasma derived product, there may be a risk of transmission of infectious agents, e.g. viruses and, the
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
2. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
3. ViroPharma Announces Discontinuation of HCV-796 Development
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. ViroPharma to Present at the Natixis Bleichroeder Conference
7. ViroPharma to Present at Three Upcoming Healthcare Conferences
8. Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease
9. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
10. Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring
11. Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 2014  The acceptance of two abstracts on ... Congress demonstrates continued interest in the Eclipse System, ... control. One of the abstracts, presented by Catherine ... of Urogynecology and Reconstructive Pelvic Surgery at the ... Best Written Abstract on Urogynecology/Pelvic Floor Disorders/Vaginal Surgery. ...
(Date:11/21/2014)... , Nov. 20, 2014 Oxis International, Inc. ... , the election of Anthony J. Cataldo as ... Effective November 19, 2014, Ken Eaton ... the Board of Directors of Oxis International, Inc. to pursue ... has been named Chief Executive Officer of Oxis International, Inc. ...
(Date:11/18/2014)... Mass. , Nov. 18, 2014  NxStage ... ), a leading manufacturer of innovative dialysis ... new  Streamline® Express dialyzer for the in-center, ... tubing set, which is designed to reduce the ... to reduce the number of touch point contamination ...
Breaking Medicine Technology:LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 3OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood Tubing Set 2
... N.Y., Sept. 1, 2011 VirtualScopics, Inc. (NASDAQ: ... for clinical trials, announced today it has been invited ... Investment Conference. The conference will be held at the ... 11-13, 2011. The presentation by VirtualScopics, Chief ...
... Hill-Rom Holdings, Inc. (NYSE: HRC ) announced ... 2011 fourth quarter dividend of $0.1125 per share. This dividend ... as of September 16, 2011. ... a leading worldwide manufacturer and provider of medical technologies and ...
Cached Medicine Technology:VirtualScopics to Present at Rodman & Renshaw Annual Global Investment Conference 2VirtualScopics to Present at Rodman & Renshaw Annual Global Investment Conference 3
(Date:11/22/2014)... November 22, 2014 The topic of ... of block retaining walls. The article states that, “While they ... several necessary steps that go into creating this powerful look.” ... a retaining wall is choosing which kind of block matches ... , B&D Rockeries says, “The two main options are concrete ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 Recently, UWDress.com ... wedding guest dresses . In addition, the company ... products. , As a leading online supplier of ... of beautiful outfits. The unusual best wedding guest gowns ... Besides the amazing designs, this new selection is famous ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 A ... was announced today which safely detects and identifies ... frequency radio waves. Developed by RHT SpectraSafe, the ... hosts broad applications in other areas including medical, ... security. , Using high frequency radio waves that ...
(Date:11/22/2014)... A Xarelto lawsuit has been filed on behalf ... million in damages from the makers and marketers of the ... the woman began using Xarelto in March 2012 and used ... she suffered life-threatening bleeding in July 2012 and as a ... emotional distress. The lawsuit purports that the woman’s injuries are ...
(Date:11/22/2014)... HealthDay Reporter FRIDAY, Nov. 21, 2014 (HealthDay ... in an ambulance by a neurologist equipped with a CT ... patients get the clot dissolver -- tissue plasminogen activator (tPA) ... noted. For the best outcome, the drug needs to be ... researchers said. "The so-called ,golden hour, is associated with ...
Breaking Medicine News(10 mins):Health News:5 Step Installment of Block Retaining Walls is Topic of Latest Article by B&D Rockeries 2Health News:Best Wedding Guest dresses Introduced by UWDress.com 2Health News:RHT SpectraSafe announces a Radical New Airport Security Technology that Is More Effective, Less Invasive 2Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 2Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 3Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 4Health News:Special Ambulance Delivers Vital Stroke Care More Quickly 2Health News:Special Ambulance Delivers Vital Stroke Care More Quickly 3
... a National CompetitionCINCINNATI, March 31 The Prilosec OTC(R) ... nation and it is giving fans the opportunity to ... win tickets to upcoming NASCAR(R) Sprint Cup Series(TM) races. ... across the country will be firing up their grills ...
... ... be available in one year-,BELLEVILLE, ON, March 31 ... a research-based, technology-driven Canadian biopharmaceutical company, today announced ... Phase III registration trial evaluating Urocidin(TM) in the ...
... of potential medical problemsHONOLULU, March 31 A new ... there are significant benefits for patients and nurses when ... "The outcomes were definitive," stated Dr. Patrick Sullivan, President ... monitoring provides an early alert to RNs about potential ...
... Health Care Provides Extensive Services & SupportSAN FRANCISCO, March ... of in home support and recovery services has announced ... Interim HomeStyle Services first opened its San Francisco ... to help people remain independent as they age or ...
... Wilhelm uses latest technology to give patients the ability to improve smile ... ... Dr. Wilhelm, DMD MSD, announced today that he is providing patients with ... giving patients the appearance of a perfect set of teeth and an ...
... Urgent Care Center. Hoboken residents now have much needed option for treatment ... ... -- Hoboken families now have a convenient place to go for most ... Hoboken,s first Urgent Care center and a medical facility like no other ...
Cached Medicine News:Health News:Prilosec OTC(R) Fires Up A BBQ Tour for NASCAR(R) Fans 2Health News:Prilosec OTC(R) Fires Up A BBQ Tour for NASCAR(R) Fans 3Health News:Prilosec OTC(R) Fires Up A BBQ Tour for NASCAR(R) Fans 4Health News:Bioniche Completes Recruitment in First Phase III Clinical Trial with Urocidin(TM) 2Health News:Bioniche Completes Recruitment in First Phase III Clinical Trial with Urocidin(TM) 3Health News:Study Shows Patients & Nurses Benefit From Continuous Vigilance Monitoring 2Health News:Nation's Largest Home Care Provider Welcomes New Management Team to San Francisco Office 2Health News:Dr. Wilhelm, DMD MSD, Makes Clients Smile with New Easy Smile Dental Appliance 2Health News:Dr. Wilhelm, DMD MSD, Makes Clients Smile with New Easy Smile Dental Appliance 3Health News:PromptMD Announces the Opening of their First Urgent Care Center at 309 First Street in Hoboken 2
... has been manufacturing the Anne Klein brand ... eyewear collections are designed for an all-female ... Anne Klein eyewear identifies herself with the ... career woman who is image-conscious and quality-conscious ...
... eyewear designs with children in mind, making ... and stay-put cable temples. Its not surprising ... Research as the best selling childrens collection ... so popular is its ability to keep ...
... frame mounting technology has redefined rimless collections ... taper at the end of each frame ... of the bushing that mounts within the ... a secure fit is created that far ...
... In 1993, Kate Spade entered the accessories world ... fabric. Since then, she has taken her simple ... accessory brand. Clean, modern shapes, a nod to ... element of surprise are the fundamental principles of ...
Medicine Products: